Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triheptanoin in Rett Syndrome
NCT03059160Phase 2Unknown
- Sponsor
- Sheba Medical Center
- Start
- Apr 2017
- Primary completion
- Apr 2018
01
Overview
A Phase 2 trial of triheptanoin in Rett syndrome (RTT), sponsored by Sheba Medical Center. Status: unknown.
02
Drugs
triheptanoin
03
Conditions
Rett syndrome (RTT)
Beyond the preview
Go deeper on NCT03059160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03059160.